Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Medical Imaging's Debt-to-EBITDA or its related term are showing as below:
MEDD's Debt-to-EBITDA is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.32 * Ranked among companies with meaningful Debt-to-EBITDA only.
Medical Imaging (OTCPK:MEDD) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Medical Imaging Debt-to-EBITDA Related Terms
Medical Imaging Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Medical Imaging's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDD vs TEAR, INVB, DCTH: Debt-to-EBITDA Comparison
For the Diagnostics & Research subindustry, Medical Imaging's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Imaging Debt-to-EBITDA vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Medical Imaging's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Medical Imaging's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Sep. 2018) EBITDA data.
Medical Imaging (MEDD) has a Debt-to-EBITDA of 37.81 as of Sep. 2018. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Medical Imaging.
Is Medical Imaging's Debt-to-EBITDA too high?
Medical Imaging's current Debt-to-EBITDA is 37.81. The Medical Diagnostics & Research industry median Debt-to-EBITDA is 2.32. Medical Imaging's value of 37.81 is 1529.7% above this industry median.
How does Medical Imaging's Debt-to-EBITDA compare to TEAR and INVB?
Medical Imaging's Debt-to-EBITDA of 37.81 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Debt-to-EBITDA is 2.32. Medical Imaging's value of 37.81 is 1529.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Diagnostics & Research company?
The median Debt-to-EBITDA among Medical Diagnostics & Research companies is 2.32, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Imaging's current Debt-to-EBITDA of 37.81 is 1529.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Medical Imaging. For the Medical Diagnostics & Research industry, the median Debt-to-EBITDA is 2.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Imaging's current Debt-to-EBITDA is 37.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Imaging stock overvalued right now?
Medical Imaging (MEDD) has a current Debt-to-EBITDA of 37.81. The current Debt-to-EBITDA is 37.81 and 1529.7% above the Medical Diagnostics & Research industry median of 2.32. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Medical Imaging (MEDD), the current Debt-to-EBITDA is 37.81 as of Sep. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medical Imaging Corp is a United States-based healthcare services company focused on the acquisition of existing full-service imaging clinics. Through its subsidiaries, the firm provides medical diagnostic imaging services. The services provided include magnetic resonance imaging, CT scans, ultrasound, X-ray, and others. The group has operations in the United States and Canada. The organization generates revenue from the medical scans services and teleradiology services, of which medical scans services contributes the maximum to the revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDD has been successfully added to your 
